{"id":"CHEMBL1082723","canonicalSmiles":"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12","inchiKey":"CKLPLPZSUQEDRT-WPCRTTGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPARGAMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cipargamin","KAE-609","KAE609","Kae609","NITD-609","NITD609"],"crossReferences":{"drugbank":["DB12306"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1120","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBSALICYLATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bismukote","Corrective Suspension","Gastro-Cote","Pepto-Bismol"],"synonyms":["Bismuth salicylate","Bismuth subsalicylate","NSC-759117"],"crossReferences":{"PubChem":["144205951","225144280","29218057"],"Wikipedia":["Bismuth_subsalicylate"],"chEBI":["261649"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0009130","HP_0002014","EFO_0000574","EFO_1000961","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for nausea and diarrhea and has 2 investigational indications."}
{"id":"CHEMBL1161998","canonicalSmiles":"O=C(CO)COP(=O)(O)O","inchiKey":"GNGACRATGGDKBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161998","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04326"],"chEBI":["16108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197118","canonicalSmiles":"CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1","inchiKey":"HJJAYSSCWGUPKO-ABAIWWIYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1197118","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07193"]},"childChemblIds":["CHEMBL559940"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200855","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)[O-])c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]","inchiKey":"ZBBCUBMBMZNEME-QBGWIPKPSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"TICARCILLIN DISODIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1449","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ticar"],"synonyms":["BRL 2288","BRL-2288","Disodium ticarcillin","Monapen","NSC-759166","Ticarcillin disodium","Ticarcillin disodium salt","Ticarcillin sodium","Ticarpen","Ticillin"],"crossReferences":{"PubChem":["11112962","856016"],"chEBI":["35017"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for infection and has 2 investigational indications."}
{"id":"CHEMBL1200880","canonicalSmiles":"COS(=O)(=O)[O-].C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1","inchiKey":"BREMLQBSKCSNNH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHEMANIL METHYLSULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201340","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prantal"],"synonyms":["Diphemanil methylsulfate","Diphemanil methylsulphate","Diphemanil metilsulfate","NSC-41725"],"crossReferences":{"PubChem":["144203900","170464876","56463612"],"Wikipedia":["Diphemanil_metilsulfate"],"chEBI":["59782"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200925","canonicalSmiles":"O=P([O-])(O)O.[K+]","inchiKey":"GNSKLFRGEWLPPA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM PHOSPHATE, MONOBASIC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pot dihydrogen phos"],"synonyms":["Monobasic potassium phosphate","Potassium phosphate, monobasic"],"crossReferences":{"DailyMed":["potassium%20phosphate,%20monobasic"],"DrugCentral":["4480"],"Wikipedia":["Monopotassium_phosphate"],"drugbank":["DB09413"],"chEBI":["63036"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hypophosphatemia."}
{"id":"CHEMBL1201420","drugType":"Enzyme","blackBoxWarning":false,"name":"UROKINASE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abbokinase","Kinlytic","Ukidan"],"synonyms":["Kinase (enzyme-activating), uro-","Urinary plasminogen activator","Urokinase"],"crossReferences":{"DrugCentral":["5109"],"Wikipedia":["Urokinase"]},"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0009680","EFO_0003097","EFO_0008585","EFO_0000544","EFO_0003827","EFO_0001645","EFO_0000712","EFO_0000612","HP_0004419"],"count":9},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for recurrent thrombophlebitis and has 6 investigational indications."}
{"id":"CHEMBL1201454","drugType":"Small molecule","blackBoxWarning":false,"name":"ALSEROXYLON","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rautensin","Rauwiloid"],"synonyms":["Alseroxylon"],"crossReferences":{"Wikipedia":["Alseroxylon"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201464","drugType":"Protein","blackBoxWarning":false,"name":"CHORIOGONADOTROPIN ALFA","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ovidrel","Ovitrelle"],"synonyms":["ATC CODE G03 GA GONADOTROPINS","Choriogonadotropin alfa","Choriogonadotropin alpha","Choriongonadotropin alfa","Chorionic gonadotrophin alfa","Fe-999302"],"crossReferences":{"DailyMed":["choriogonadotropin%20alfa"],"DrugCentral":["5149"]},"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["Orphanet_145","Orphanet_64739","MONDO_0002146","EFO_0000545","EFO_0004266","EFO_0001073","EFO_0000660"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201478","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYETHYLENE GLYCOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atpeg 300","Carbowax sentry","Lutrol e","Pluracol e","Polyglycol e 300, e 400, e 1450, e 8000"],"synonyms":["E-1521","E1521","INS NO.1521","INS-1521","Macrogol","Macrogol 3350","NER-1006","NER1006","PEG-BASED LAXATIVE NER1006","Polyethylene glycol","Polyethylene glycol 3350","Polyethylene glycol, unspecified","Polyethylene glycols","Polyethylene oxide"],"crossReferences":{"Wikipedia":["Polyethylene_glycol"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL1201594","drugType":"Enzyme","blackBoxWarning":true,"name":"RASBURICASE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elitek","Fasturtec"],"synonyms":["Rasburicase","Rasuritek","SR-29142","SR29142","Urate oxidase"],"crossReferences":{"DailyMed":["rasburicase"],"DrugCentral":["4994"],"Wikipedia":["Rasburicase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213351","canonicalSmiles":"CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C","inchiKey":"XLMALTXPSGQGBX-GCJKJVERSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPOXYPHENE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2014},"tradeNames":[],"synonyms":["Algafan","D-propoxyphene","Depromic","Dextropropoxyphen","Dextropropoxyphene","J5.928E","Levopropoxyphene","Propoxyphene","Propoxyphene, d-","SK-65"],"crossReferences":{"DailyMed":["propoxyphene%20napsylate"],"Wikipedia":["Dextropropoxyphene","Levopropoxyphene"],"drugbank":["DB00647"],"chEBI":["51173"]},"childChemblIds":["CHEMBL3989716","CHEMBL1237104"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for pain. It was withdrawn in United States  in 2014 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213553","canonicalSmiles":"CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1","inchiKey":"ISZNZKHCRKXXAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROGUANIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorproguanil","Proguanil hydrochloride related compound f"],"crossReferences":{"drugbank":["DB12314"]},"childChemblIds":["CHEMBL2107534"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1233922","canonicalSmiles":"Cc1nc(-c2ccnc(N)n2)cn1Cc1c(Cl)cccc1Cl","inchiKey":"CKSSZTMRRVJNNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233922","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08076"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235568","canonicalSmiles":"CS(=O)(=O)Nc1cccc2cccnc12","inchiKey":"XYEPUTZVZYUENX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235568","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["7974518"],"drugbank":["DB08451"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235787","canonicalSmiles":"C[C@H](N)P(=O)(O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"MMWNOZXGYRPSCJ-LZQZEXGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08506"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236661","canonicalSmiles":"Cc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1","inchiKey":"FYCOTGCSHZKHPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08699"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236690","canonicalSmiles":"C=CS(=O)(=O)O","inchiKey":"NLVXSWCKKBEXTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINYLSULFONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124896644"],"drugbank":["DB04359"]},"childChemblIds":["CHEMBL2106422"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12420","canonicalSmiles":"CN(C)CCc1c[nH]c2ccccc12","inchiKey":"DMULVCHRPCFFGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N,N-DIMETHYLTRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N,N-Dimethyltryptamine"],"crossReferences":{"Wikipedia":["Dimethyltryptamine"],"drugbank":["DB01488"],"chEBI":["28969"]},"childChemblIds":["CHEMBL3183055"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13280","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21","inchiKey":"PPTYJKAXVCCBDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNITRAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," unapproved in United States"],"classes":["Misuse"],"year":1996},"tradeNames":["Rohypnol"],"synonyms":["Flunitrazepam","N05CD03","RO 5-4200","RO-5-4200","RO-54200"],"crossReferences":{"Wikipedia":["Flunitrazepam"],"drugbank":["DB01544"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France and  unapproved in United States initially in 1996 due to Misuse."}
{"id":"CHEMBL1357","canonicalSmiles":"CC(O)C(=O)[O-].[Na+]","inchiKey":"NGSFWBMYFKHRBD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM LACTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sod lact co"],"synonyms":["Compound solution of sodium lactate","E-325","E325","INS NO.325","INS-325","NSC-31718","Natrum lacticum","Sodium (lactate) anhydrous","Sodium Lactate","Sodium dl-lactate","Sodium lactate","Sodium lactate solution"],"crossReferences":{"DrugCentral":["4202"],"Wikipedia":["Sodium_lactate"],"chEBI":["75228"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL13817","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12","inchiKey":"UMUPQWIGCOZEOY-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUTAMOREN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibutamoren","L-163,191","MK-677"],"childChemblIds":["CHEMBL542653","CHEMBL2105872"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["GO_0007568","EFO_0005687"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL13960","canonicalSmiles":"O=C(O)C(Cl)Cl","inchiKey":"JXTHNDFMNIQAHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROACETIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bichloracetic acid","Bichloroacetic acid","Dichloracetic acid","Dichlorethanoic acid","Dichloroacetate","Dichloroacetic acid","Dichloroethanoic acid","NSC-2654"],"crossReferences":{"PubChem":["144204684","144209561","144210737","17389935","26753010"],"Wikipedia":["Dichloroacetic_acid"],"drugbank":["DB08809"],"chEBI":["36386"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL14173","canonicalSmiles":"Nc1ccccc1C(=O)O","inchiKey":"RWZYAGGXGHYGMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTHRANILIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Benzoic Acid","2-Aminobenzoic Acid","Antranilic Acid"],"crossReferences":{"PubChem":["144204646","144207901","170465552","17390039"],"Wikipedia":["Anthranilic_acid"],"drugbank":["DB04166"],"chEBI":["30754"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL151663","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cc3ccccc3o2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1c2ccccc2C[C@H]1O","inchiKey":"AOMZDQMIOCTPQP-CFSTZTOESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL151663","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL152632","canonicalSmiles":"O=C1NCCN1c1ncc([N+](=O)[O-])s1","inchiKey":"RDXLYGJSWZYTFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIRIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA 32644","BA-32644","CIBA 32644BA","NSC-136947","Niridazole","Niridazolum"],"crossReferences":{"PubChem":["11112162","144203894","56463576"],"drugbank":["DB13661"],"chEBI":["82349"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1568698","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"PGTVWKLGGCQMBR-FLBATMFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANAXOLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCD 1042","CCD-1042","Ganaxolone"],"crossReferences":{"PubChem":["144205817","170466317","29217560","50111707","90341411"],"drugbank":["DB05087"]},"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000182256","ENSG00000102287","ENSG00000022355","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0008526","EFO_0004319","EFO_1000877","EFO_0000474","Orphanet_3451","EFO_0004263","Orphanet_805","MONDO_0100039","EFO_0001358","HP_0001250","Orphanet_908"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1618340","canonicalSmiles":"C[N+](C)(C)CCOP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O","inchiKey":"RZZPDXZPRHQOCG-OJAKKHQRSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CITICOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citicoline","IP 302","IP-302","NSC-122002"],"crossReferences":{"Wikipedia":["Citicoline"],"chEBI":["49086"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1697708","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"GTGQRSIMEUWHPA-ZBJAFUORSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MEZLOCILLIN SODIUM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1731","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mezlin"],"synonyms":["Mezlocillin sodium","Mezlocillin sodium monohydrate","Mezlocillin sodium salt"],"crossReferences":{"chEBI":["52067"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and has 1 investigational indication."}
{"id":"CHEMBL1702","canonicalSmiles":"CNCC[C@@H](Oc1ccccc1C)c1ccccc1.Cl","inchiKey":"LUCXVPAZUDVVBT-UNTBIKODSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ATOMOXETINE HYDROCHLORIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL641","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atomoxetine hydrochloride","Strattera"],"synonyms":["Atomoxetine (as hydrochloride)","Atomoxetine hcl","Atomoxetine hydrochloride","LY-139603","NSC-759104","Tomoxetine","Tomoxetine hydrochloride"],"crossReferences":{"DailyMed":["atomoxetine%20hydrochloride"],"PubChem":["144203843","170465067","49681605"],"chEBI":["331697"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003890","MONDO_0002050","HP_0010865","MONDO_0004975","EFO_0004701","EFO_0005230","EFO_0003918"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for attention deficit hyperactivity disorder and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL170630","canonicalSmiles":"CS(=O)(=O)OCCOS(C)(=O)=O","inchiKey":"QSQFARNGNIZGAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHANE DIMETHANE SULFONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethane dimethane sulfonate","Methanesulfonic Acid 2-Methanesulfonyloxy-Ethyl Ester"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1736151","canonicalSmiles":"CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1","inchiKey":"OEGDFSLNGABBKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAFENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etafenone","Etafenone hydrochloride"],"crossReferences":{"PubChem":["144205399","170466000","29216166"],"drugbank":["DB13845"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743044","drugType":"Antibody","blackBoxWarning":false,"name":"NAMILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-hgm-csf igg1","MT-203","MT203","Namilumab"],"linkedTargets":{"rows":["ENSG00000164400"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0003898","EFO_0000676"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743079","drugType":"Antibody","blackBoxWarning":false,"name":"TEPROTUMUMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tepezza"],"synonyms":["Onilcamotide","R-1507","RG-1507","RG1507","RO-4858696","RO-4858696-000","RO-4858696000","RO4858696","RO4858696-000","RV-001","RV-001 MONOCLONAL","RV001","RV001 MONOCLONAL","Rhoc peptide vaccine rv001v","Tepezza","Teprotumumab","Teprotumumab-trbw"],"crossReferences":{"DailyMed":["teprotumumab-trbw"]},"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000404","EFO_1001466","MONDO_0007254","EFO_0009321","EFO_0000691","EFO_0003060"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for graves ophthalmopathy and has 5 investigational indications."}
{"id":"CHEMBL175198","canonicalSmiles":"CCCCCNC(=O)[C@H](Cc1ccc(OCC(=O)O)c(C(=O)O)c1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)O","inchiKey":"PUAJYWYRZTYQKS-GOTSBHOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175198","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1767164","canonicalSmiles":"O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1","inchiKey":"YANGEESWIGIKOP-UUWRZZSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-1004723","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK1004723","Gsk-1004723","Gsk1004723"],"crossReferences":{"drugbank":["DB12806"]},"childChemblIds":["CHEMBL3215857","CHEMBL1767170"],"linkedTargets":{"rows":["ENSG00000101180","ENSG00000196639"],"count":2},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003956"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL183817","canonicalSmiles":"COC(=O)[C@@H]1C[C@H](C(=O)O)O[C@H]1[C@H](CC(C)C)NC(C)=O","inchiKey":"MUJPWSPVNZGJOW-WRWGMCAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL183817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03257"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1851805","canonicalSmiles":"CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1","inchiKey":"QTGAJCQTLIRCFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPACETAMOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Propacetamol"],"crossReferences":{"PubChem":["170466215"],"drugbank":["DB09288"]},"childChemblIds":["CHEMBL1795480"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1885437","canonicalSmiles":"CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1","inchiKey":"BSHWLCACYCVCJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPRAZINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eprazinone","Eprazinone hydrochloride"],"crossReferences":{"PubChem":["50112699"],"drugbank":["DB08990"],"chEBI":["82716"]},"childChemblIds":["CHEMBL2359721"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1957287","canonicalSmiles":"Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1","inchiKey":"XBEQSQDCBSKCHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGOBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-333126","GS-9190","Tegobuvir"],"crossReferences":{"drugbank":["DB11852"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1997223","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1","inchiKey":"YMRFZDHYDKZXPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1997223","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["511307"],"drugbank":["DB09180"],"chEBI":["61099"]},"childChemblIds":["CHEMBL2354465"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103791","canonicalSmiles":"CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12","inchiKey":"UAMAIHOEGLEXSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADIPIPLON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adipiplon","Apiplon","NG2-73"],"crossReferences":{"drugbank":["DB06579"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103851","canonicalSmiles":"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"FOFDIMHVKGYHRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMUVATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amuvatinib","HPK 56","HPK-56","HPK56","MP 470","MP-470","MP470"],"crossReferences":{"PubChem":["137276002"],"drugbank":["DB12742"]},"childChemblIds":["CHEMBL4071984","CHEMBL4061772","CHEMBL4092757","CHEMBL2105685","CHEMBL4063359","CHEMBL4099995","CHEMBL4085000"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000157404","ENSG00000105976","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000702"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104432","canonicalSmiles":"FCC(F)(F)F","inchiKey":"LVGUZGTVOIAKKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORFLURANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dymel 134a","Forane 134a","Freon 134a","Genetron 134a","HFA 134A","HFA-134-A","HFC-134A","Hfa-134a","Hydrofluorocarbon 134a","Norflurane","R-134A","Solkane 134a","Suva 134a","Tetrafluoroethane"],"crossReferences":{"drugbank":["DB13116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106615","canonicalSmiles":"CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12","inchiKey":"OMZAMQFQZMUNTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAZEDOXIFENE ACETATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL46740","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bazedoxifen acetate","Bazedoxifene acetate","Conbriza","Duavive","WAY-140424"],"crossReferences":{"DailyMed":["bazedoxifene%20acetate"],"PubChem":["144206564","170466793"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0005301","EFO_0003854","EFO_0003929","EFO_0003882","EFO_0003922"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for postmenopausal osteoporosis and has 3 investigational indications."}
{"id":"CHEMBL2108360","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"MIRAVIRSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Miravirsen","SPC-3649","SPC3649"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108681","drugType":"Antibody","blackBoxWarning":false,"name":"TILDRAKIZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilumetri","Ilumya"],"synonyms":["MK-3222","SCH-900222","Tildrakizumab","Tildrakizumab-asmn"],"crossReferences":{"DailyMed":["tildrakizumab-asmn"]},"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_0000676","EFO_0000540","MONDO_0008315","EFO_0000311"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2109027","drugType":"Unknown","blackBoxWarning":false,"name":"BROMELAINS","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ananase"],"synonyms":["Bromelain","Bromelains","Bromelin","Debridase","E-1101(iii)","Edemase d","Extranase","Ins no.1101(iii)","Ins-1101(iii)","Pinase","Pineapple enzyme","Traumanase"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for skin ulcer and has 1 investigational indication."}
{"id":"CHEMBL2109477","drugType":"Antibody","blackBoxWarning":false,"name":"SELICRELUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B-cell surface antigen cd40","CD40","CP 870,893","CP-870,893","CP-870893","Cd40l receptor","Cdw40","Cp-870893","RG-7876","RG7876","RO-7009789","Selicrelumab","Tnfrsf5"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000044","EFO_0000096","EFO_0003860","EFO_0000756","MONDO_0007254","EFO_1001951"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109480","drugType":"Antibody","blackBoxWarning":false,"name":"AHN-12","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AHN-12","Ahn-12"],"linkedTargets":{"rows":["ENSG00000081237"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0000339","EFO_0000220","EFO_0000222"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109491","drugType":"Antibody","blackBoxWarning":false,"name":"COL-1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COL-1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109533","drugType":"Antibody","blackBoxWarning":false,"name":"ORTICUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-204","MLDL-1278A","Orticumab","RG-7418"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109534","drugType":"Antibody","blackBoxWarning":false,"name":"PF-03732010","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03732010","PF03732010","Pf-03732010"],"linkedTargets":{"rows":["ENSG00000062038"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109546","drugType":"Antibody","blackBoxWarning":false,"name":"SAR-279356","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-pnag antibody f598","F-598","F598","SAR-279356","Sar-279356"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109576","drugType":"Antibody","blackBoxWarning":false,"name":"IDEC-159","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-159"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110555","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM MEBROFENIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["technetium%20tc-99m%20mebrofenin%20kit"]},"childChemblIds":["CHEMBL1200421"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and has 1 investigational indication."}
{"id":"CHEMBL2110862","canonicalSmiles":"CN(C)CCOCCOC(=O)N1c2ccccc2Sc2ccccc21","inchiKey":"OOVJCSPCMCAXEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHOXANATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethoxanate"],"crossReferences":{"drugbank":["DB13794"]},"childChemblIds":["CHEMBL2106376"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110959","canonicalSmiles":"CC(C)CNCCOC(=O)c1cccc(N)c1","inchiKey":"BXMFKNRZTLNAFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METABUTETHAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metabutethamine"],"crossReferences":{"drugbank":["DB13578"],"chEBI":["81295"]},"childChemblIds":["CHEMBL2106833"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL212522","canonicalSmiles":"O=C(O)c1cc(Br)ccc1NS(=O)(=O)c1ccc(Cl)cc1","inchiKey":"JDVLYAYDIMUAAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL212522","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2151570","canonicalSmiles":"c1cc2cc(-c3ccc(O[C@H]4CN5CCC4CC5)nn3)ccc2[nH]1","inchiKey":"LUKNJAQKVPBDSC-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-107","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-PR1","Abt-107","Abt-107 free base"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2165326","canonicalSmiles":"NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1","inchiKey":"DKULOVKANLVDEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APROCITENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-132577","Act-132577","Aprocitentan","Macitentan metabolite m6"],"crossReferences":{"drugbank":["DB15059"],"chEBI":["76609"]},"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0001134","EFO_0001421","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2219740","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO.[Ca+2]","inchiKey":"YPCRNBPOUVJVMU-LCGAVOCYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLUBIONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neo-calglucon"],"synonyms":["Calcium glubionate"],"crossReferences":{"drugbank":["DB13142"]},"childChemblIds":["CHEMBL2104594"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2373108","canonicalSmiles":"CCCCN(CCCC)C(=S)[S-].CCCCN(CCCC)C(=S)[S-].[Zn+2]","inchiKey":"BOXSVZNGTQTENJ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2373108","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2027996","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206589","144209799"],"drugbank":["DB14194"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243712","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC","inchiKey":"NTJOBXMMWNYJFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMISULPRIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Barhemsys","Solian","Solian 100","Solian 200","Solian 400","Solian 50"],"synonyms":["APD-421","APD421","Aminosultopride","Amisulpride","DAN-2163","Deniban","NSC-760085","Socian","Sulamid"],"crossReferences":{"DailyMed":["amisulpride"],"PubChem":["124891581","144206943","170466480","26719747","26719748","26753203"],"Wikipedia":["Amisulpride"],"drugbank":["DB06288"],"chEBI":["64045"]},"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000164270","ENSG00000102468","ENSG00000168830","ENSG00000186090","ENSG00000157219","ENSG00000178084","ENSG00000186038","ENSG00000148680","ENSG00000147246","ENSG00000135312","ENSG00000135914","ENSG00000179546","ENSG00000149305","ENSG00000158748","ENSG00000151577","ENSG00000179097","ENSG00000166736"],"count":19},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004280","MONDO_0002009","EFO_0006911","HP_0000726","EFO_0000677","EFO_0005407","EFO_0000289","MONDO_0002050","EFO_0003884","HP_0002017","EFO_0004888","EFO_0004242","EFO_0005230","EFO_0005411","EFO_0004215"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL256315","canonicalSmiles":"CC(C)(C)CC(=O)O/N=C/c1ccc(O)cc1","inchiKey":"IRHAIEVALGHVLW-NTEUORMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL256315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08335"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258728","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)c(=O)n1","inchiKey":"UOOOPKANIPLQPU-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Cytidine 3'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine 3'-Phosphate"],"crossReferences":{"PubChem":["26754279"],"drugbank":["DB01961"],"chEBI":["53013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261720","canonicalSmiles":"Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F","inchiKey":"ARIOBGGRZJITQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL261720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261932","canonicalSmiles":"O=C(C[C@H](CSc1ccccc1)C(=O)O)c1ccc(-c2ccc(Cl)cc2)cc1","inchiKey":"JXAGDPXECXQWBC-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANOMASTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 12-9566","BAY-12-9566","BAY-129566","Tanomastat"],"crossReferences":{"drugbank":["DB06276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262777","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O","inchiKey":"MYPYJXKWCTUITO-LYRMYLQWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VANCOMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vancoled","Vancomycin","Vancor"],"crossReferences":{"DailyMed":["vancomycin%20hydrochloride"],"PubChem":["90341222"],"Wikipedia":["Vancomycin"],"drugbank":["DB00512"],"chEBI":["28001"]},"childChemblIds":["CHEMBL1200628"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 11 approved and 38 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL272485","canonicalSmiles":"CCCCOC(=O)c1ccccc1C(=O)OCCCC","inchiKey":"DOIRQSBPFJWKBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUTYL PHTHALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl phthalate","Corflex 440","Di-n-butyl phthalate","Dibutyl phthalate","Dibutylphthalate","Ergoplast fdb","Genoplast b","Hatco dbp","Kodaflex dbp","Monocizer dbp","NSC-6370","Palatinol c","Plasthall dbp","Polycizer dbp","Ruifeng vp 201","Staflex dbp","Unimoll db","Vestinol c","Vp-201","Witcizer 300","Yh-1bd2"],"crossReferences":{"PubChem":["144208927","144211297","17389633","26747249","56462803"],"drugbank":["DB13716"],"chEBI":["34687"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL28564","canonicalSmiles":"OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1","inchiKey":"GGUSQTSTQSHJAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELIPRODIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eliprodil"],"crossReferences":{"PubChem":["144204745","170466155","26753224","26753225","26753226","90340808"],"Wikipedia":["Eliprodil"],"drugbank":["DB12869"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137306","canonicalSmiles":"N[C@H](CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O","inchiKey":"CATMPQFFVNKDEY-DGCLKSJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORILOTIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO-805","Apo805","Orilotimod","Thymodepressin","Timodepressin"],"childChemblIds":["CHEMBL3137328"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL329363","canonicalSmiles":"CCN(CC)S(=O)(=O)c1ccc(Cl)c(C(=O)Nc2sc3c(c2C#N)CCC3)c1","inchiKey":"MZCDQILVXXIMEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329363","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3393588","canonicalSmiles":"O=C(c1cccnc1)N1CCN2C(=O)c3ccncc3[C@]12c1ccc(Cl)cc1","inchiKey":"QZSZPSDRJPPZDZ-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BTA-9881","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-9639","BTA9881","Bta-9881","Bta9881","MEDI-564","Medi 564"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3402762","canonicalSmiles":"CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1","inchiKey":"AHYMHWXQRWRBKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPOTINIB","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["EMD 1214063","EMD-1214063","EMD1214063","Emd-1214063","MSC-2156119","MSC-2156119J","MSC2156119","Tepotinib"],"crossReferences":{"drugbank":["DB15133"]},"childChemblIds":["CHEMBL4594292"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","EFO_0001421","EFO_0004142","EFO_0003833","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for neoplasm and non-small cell lung carcinoma and has 5 investigational indications."}
{"id":"CHEMBL343892","canonicalSmiles":"COC(=O)C1CCN(C(=O)[C@H](Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1","inchiKey":"JJLGQWCKMHPBEB-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL343892","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544955","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1217389","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1217389","Bay-1217389"],"linkedTargets":{"rows":["ENSG00000112742"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545000","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2201","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-2201"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545087","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK159802","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk159802"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545150","drugType":"Small molecule","blackBoxWarning":false,"name":"AZM-475271","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azm 475271","Azm-475271","M-475271"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545179","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7451","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd-7451"],"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0000519"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545309","canonicalSmiles":"C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.CC(=O)O","inchiKey":"WSMXIQXWHPSVDE-ZPJPNJFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEFAMULIN ACETATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3291398","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xenleta"],"synonyms":["BC-3781.Ac","Lefamulin acetate"],"crossReferences":{"DailyMed":["lefamulin%20acetate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for bacterial pneumonia."}
{"id":"CHEMBL3545346","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2516","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd2516"],"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545395","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-811283","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi-811283"],"linkedTargets":{"rows":["ENSG00000178999"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL356479","canonicalSmiles":"CCCCC(CC)C1NC(=O)N(SC(Cl)(Cl)Cl)C1=O","inchiKey":"VOGJJBHRUDVEFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORDANTOIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlordantoin","Clodantoin","NSC-231427"],"crossReferences":{"drugbank":["DB13516"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3578202","canonicalSmiles":"O=C(O)CCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCC(=O)NCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)O)c1","inchiKey":"QJUIUFGOTBRHKP-LQJZCPKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOZETOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gozetotide"],"childChemblIds":["CHEMBL4650355"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL37676","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2","inchiKey":"SEBPXHSZHLFWRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APC-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APC-100","Apc-100","Chromane c1","NSC-226236"],"crossReferences":{"drugbank":["DB13111"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL385937","canonicalSmiles":"Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1","inchiKey":"YEIASMOUYNOXGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06925"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989506","canonicalSmiles":"CN(C)CCOCC(=O)NC12CC3CC(CC(C3)C1)C2","inchiKey":"UXQDWARBDDDTKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROMANTADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tromantadine"],"crossReferences":{"drugbank":["DB13288"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989855","canonicalSmiles":"CN[C@@H](C)[C@@H](O)c1ccccc1.CN[C@@H](C)[C@@H](O)c1ccccc1.O=S(=O)(O)O","inchiKey":"CAVQBDOACNULDN-NRCOEFLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE SULFATE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrinol"],"synonyms":["D-pseudoephedrine sulfate","Pseudoephedrine sulfate","Pseudoephedrine sulphate","SCH 4855","SCH-4855"],"crossReferences":{"DailyMed":["pseudoephedrine%20sulfate"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003956"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and is indicated for allergic rhinitis and seasonal allergic rhinitis."}
{"id":"CHEMBL3989966","canonicalSmiles":"CC(=O)OP(=O)([O-])N(C[C@H]1CN(c2cc(F)c(N3C=CC(=O)CC3)c(F)c2F)C(=O)O1)c1ccon1.[Na+]","inchiKey":"JANNTEAGZXJITO-BTQNPOSSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CONTEZOLID ACEFOSAMIL","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4301914","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Contezolid acefosamil","MRX-4","MRX-4 SODIUM","Prodrug of contezolid (mrx-1)"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4069597","canonicalSmiles":"Cc1nc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)sc1S(N)(=O)=O","inchiKey":"IVZKZONQVYTCKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRITELIVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AIC-316","AIC316","Aic316","Pritelivir"],"crossReferences":{"drugbank":["DB11844"]},"childChemblIds":["CHEMBL4562772","CHEMBL4082238"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4076467","canonicalSmiles":"COc1c(/C=C/c2ccc(NS(C)(=O)=O)cc2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C","inchiKey":"XMZSTQYSBYEENY-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-072","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-072","Abt-072"],"crossReferences":{"drugbank":["DB15156"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL414804","drugType":"Small molecule","blackBoxWarning":true,"name":"OXALIPLATIN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eloxatin","Oxaliplatin"],"synonyms":["JM-83","L-OHP","MBP-426 (LIPOSOMAL OXALIPLATIN)","NSC-266046","Oxaliplatin","RP-54780","SR-96669","Xaliplatin"],"crossReferences":{"DailyMed":["oxaliplatin"],"DrugCentral":["4210"],"PubChem":["144206138","144206182"],"Wikipedia":["Oxaliplatin"]},"childChemblIds":["CHEMBL1983570"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for neoplasm and cancer and has 92 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL416956","canonicalSmiles":"OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1","inchiKey":"XEEQGYMUWCZPDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEFLOQUINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GNF-Pf-5544","Lariam","Mefaquin","Mefloquine","NSC-758233","RO 21-5998","RO-215998","WR 142,490"],"crossReferences":{"DailyMed":["mefloquine%20hydrochloride"],"PubChem":["174006936","26748684","29216385"],"Wikipedia":["Mefloquine"],"drugbank":["DB00358"],"chEBI":["63681"]},"childChemblIds":["CHEMBL535650"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL424","canonicalSmiles":"O=C(O)c1ccccc1O","inchiKey":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALICYLIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acnisal","Advanced pain relief callus removers","Advanced pain relief com removers","Bazuka","Clear away wart remover","Compound v","Compound w","Cuplex verruca","Dr. scholl's callus removers","Dr. scholl's corn removers","Dr. scholl's wart remover kit","Duofilm","Duofilm wart remover","Duoplant","Edinburgh","Erytex","Freezone","Gppe paint","Ionil","Ionil-plus","Jadit","Keralyt","Metanium","Necol","Noxacorn","Occlusal","Phiso-clear","Phytex","Phytocil","Posalfilin","Pyralvex","Salactol","Salatac","Salicylic acid soap","Saligel","Stri-dex","Thwart","Toepedo","Verrugon","Wartex"],"synonyms":["2-Hydroxy-benzoic acid","FEMA NO. 3985","K-557","Lamivudine impurity, salicylic acid-","Lamivudine related compound salicylic acid","NSC-180","Salicylic Acid","Salicylic acid","Salicylic acid rs"],"crossReferences":{"PubChem":["124893592","144207002","144208669","144213426","29215390","8139912"],"Wikipedia":["Salicylic_acid"],"drugbank":["DB00936"],"chEBI":["16914"]},"childChemblIds":["CHEMBL3137698"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 12 approved and 15 investigational indications."}
{"id":"CHEMBL4297405","canonicalSmiles":"NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O","inchiKey":"KJDAGXLMHXUAGV-DGWLBADLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-243","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN-7243","MLN7243","Mln7243","Tak 243","Tak-243","Uae inhibitor mln7243"],"crossReferences":{"drugbank":["DB15013"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297531","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2ccc(NC(N)=O)cc2)NC(=O)[C@H](Cc2ccc(NC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC1=O","inchiKey":"ZJZDXGQUNVNYQP-MXEXKMKYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SATOREOTIDE TETRAXETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DOTA-JR-11","Dota satoreotide","Satoreotide dota","Satoreotide tetraxetan"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297553","drugType":"Protein","blackBoxWarning":false,"name":"VALANAFUSP ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGT-181","Agt-181","Valanafusp alfa"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297583","canonicalSmiles":"Cc1nc2cc(C(=O)N(C)C)cc(O[C@H]3CCOc4cc(F)cc(F)c43)c2[nH]1","inchiKey":"CLIQCDHNPDMGSL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGOPRAZAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LXI-15028","Lxi-15028","Tegoprazan"],"linkedTargets":{"rows":["ENSG00000105675","ENSG00000186009"],"count":2},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398","EFO_0001421","EFO_0004607","EFO_1000961"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297779","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"LUMASIRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AD-65585","ALN-65585","ALN-G01","ALN-GO1","Lumasiran"],"linkedTargets":{"rows":["ENSG00000101323"],"count":1},"linkedDiseases":{"rows":["Orphanet_416","Orphanet_93598","EFO_0004253"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297784","drugType":"Unknown","blackBoxWarning":false,"name":"MK-4280","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Favezelimab","MK-4280","Mavezelimab","Mk-4280"],"linkedTargets":{"rows":["ENSG00000089692"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","EFO_0000702","EFO_0000183","EFO_0005952","EFO_0003060","EFO_1001951"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297804","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06263507","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-06263507"],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297949","drugType":"Protein","blackBoxWarning":false,"name":"AVEXITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avexitide","Exendin (9-39)","Exendin (9-39) amide","Exendin 9-39","Exendin(9-39)amide","Exendin-3 (9-39) amide"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_1001511","EFO_0001074","Orphanet_657","EFO_0001069","HP_0001943","GO_0035483","EFO_0001073","MONDO_0005148","EFO_0007318"],"count":9},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297950","drugType":"Protein","blackBoxWarning":false,"name":"BENEGRASTIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benegrastim","Efbemalenograstim alfa","F-627","Rh g-csf fc fusion protein f-627"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298092","drugType":"Antibody","blackBoxWarning":false,"name":"GLOFITAMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glofitamab","RG-6026","RG6026","RO-7082859","RO7082859","Ro-7082859","Ro7082859"],"linkedTargets":{"rows":["ENSG00000198851","ENSG00000167286","ENSG00000160654","ENSG00000156738"],"count":4},"linkedDiseases":{"rows":["MONDO_0044889","EFO_0000096","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_1001469","EFO_0005952"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4298106","drugType":"Unknown","blackBoxWarning":false,"name":"MONTMORILLONITE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diosmectite","Gelwhite gp","Gelwhite h","Gelwhite l","Montmorillonite","Montmorillonite clay","Smecdral","Smecta"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298111","drugType":"Unknown","blackBoxWarning":false,"name":"APILIMOD MESYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apilimod bis-mesylate","Apilimod dimesylate","Apilimod mesilate","Apilimod mesylate","STA 5326 MESYLATE","STA-5326 MESYLATE","Sta 5326 mesilate","Sta 5326 mesylate","Sta-5326 mesilate","Sta-5326 mesylate"],"linkedTargets":{"rows":["ENSG00000115020"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000384"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298138","canonicalSmiles":"C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1","inchiKey":"FIKPXCOQUIZNHB-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPOTRECTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Repotrectinib","TPX-0005","TRX-0005"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL457077","canonicalSmiles":"O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"YMGFTDKNIWPMGF-UCPJVGPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALVIANOLIC ACID A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dan phenolic acid a","Salvianolic acid a"],"crossReferences":{"drugbank":["DB15246"],"chEBI":["9017"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594356","drugType":"Unknown","blackBoxWarning":false,"name":"DS-8273A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-8273","DS-8273A","Ds-8273a"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594497","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"SEPOFARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EW9I3PJC3R","QR-110","QR-110 FREE ACID","Qr-110","Sepofarsen"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4594509","drugType":"Unknown","blackBoxWarning":false,"name":"TT-00420","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TT-00420","Tt-00420"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650292","drugType":"Antibody","blackBoxWarning":false,"name":"CDX-3379","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-3379","Cdx-3379","Cdx3379","KTN-3379","MEDI-3379"],"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000181"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650495","drugType":"Unknown","blackBoxWarning":false,"name":"NLY-01","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NLY-01","NLY01","Nly-01","Nly01"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL469117","canonicalSmiles":"Cc1ccc(Nc2cc(-c3ccccc3)ncn2)cc1NS(C)(=O)=O","inchiKey":"CXQRKICWSCAUGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL469117","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07175"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL476","canonicalSmiles":"CN(C)/N=N/c1[nH]cnc1C(N)=O","inchiKey":"FDKXTQMXEQVLRF-ZHACJKMWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DACARBAZINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dacarbazine","Dtic-dome"],"synonyms":["Biocarbazine r","DIC","DTIC","Dacarbasine","Dacarbazine","Dacarbazinum","Dicarbazine","NCI C04717","NSC-45388"],"crossReferences":{"DailyMed":["dacarbazine"],"PubChem":["17389952","26747399","99125"],"Wikipedia":["Dacarbazine"],"drugbank":["DB00851"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 7 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL486146","canonicalSmiles":"O=C(O)C(=O)N[C@H](Cc1ccccc1)C(=O)O","inchiKey":"ULQWGBCNOHBNDB-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL486146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08263"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49080","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1","inchiKey":"STJMRWALKKWQGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLENBUTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spiropent","Spiropent mite"],"synonyms":["Clenbuterol","Clenbuterol hydrochloride","Contraspasmin","NAB 365","NSC-758633","Planipart"],"crossReferences":{"PubChem":["144205569","170465955","26756514","29216418"],"Wikipedia":["Clenbuterol"],"drugbank":["DB01407"],"chEBI":["174690"]},"childChemblIds":["CHEMBL1330729"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","Orphanet_365","MONDO_0005180","MONDO_0004976","MONDO_0005148"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for airway obstruction and has 4 investigational indications."}
{"id":"CHEMBL511","canonicalSmiles":"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1","inchiKey":"YECBIJXISLIIDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRILAMINE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mepyramine","NSC-13136","Pyrilamine"],"crossReferences":{"PubChem":["104171213","11111639","11111640","11113355","144203781","144208176","170464656","17389532","26751558","50100317","50104164","90341279"],"Wikipedia":["Mepyramine"],"drugbank":["DB06691"],"chEBI":["6762"]},"childChemblIds":["CHEMBL1201006"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0005271","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 3 approved indications."}
{"id":"CHEMBL537669","canonicalSmiles":"COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21.Cl","inchiKey":"PIPZGJSEDRMUAW-VJDCAHTMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"YOHIMBINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL15245","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prowess plain","Yocon"],"synonyms":["NSC-19509","Yohimbine hcl","Yohimbine hydrochloride"],"crossReferences":{"PubChem":["50085982","50107142"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL554","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1","inchiKey":"BCFGMOOMADDAQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAPATINIB","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tyverb"],"synonyms":["GSK-572016","GW-2016","GW-572016","GW-572016X","GW572016","Lapatinib"],"crossReferences":{"DailyMed":["lapatinib%20ditosylate"],"PubChem":["103905567","103905568","144206058","170465125","50100107"],"Wikipedia":["Lapatinib"],"drugbank":["DB01259"],"chEBI":["49603"]},"childChemblIds":["CHEMBL1201179","CHEMBL3526325","CHEMBL1076241","CHEMBL1201183"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000365","EFO_0002938","EFO_0000756","EFO_0000681","EFO_1001465","MONDO_0007254","EFO_0005950","MONDO_0002087","EFO_0000228","EFO_0000305","MONDO_0020654","MONDO_0001187","EFO_1001951","MONDO_0001056","EFO_1001480","EFO_0006352","MONDO_0002974","EFO_0003884","MONDO_0001657","EFO_0000326","EFO_0000707","EFO_1000158","EFO_0002618","EFO_0000616","EFO_0006859","EFO_0005922","EFO_0005774","EFO_0006318","MONDO_0008170","EFO_1001512","MONDO_0007576","EFO_1001968","EFO_0000402","MONDO_0004986","EFO_0000504","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001967","MONDO_0044787","EFO_1000478","EFO_0006861","EFO_0002892","MONDO_0011962","EFO_0000574","MONDO_0024880","EFO_0000181","EFO_0000519","MONDO_0044926"],"count":50},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 5 approved and 44 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL556262","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C([C@H]3CCCO3)S[C@H]12","inchiKey":"HGGAKXAHAYOLDJ-FHZUQPTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAROPENEM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Faropenem","Fropenem"],"crossReferences":{"PubChem":["144205728","170466271"],"Wikipedia":["Faropenem"],"drugbank":["DB12190"],"chEBI":["51257"]},"childChemblIds":["CHEMBL431753"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL561","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21","inchiKey":"ZEKZLJVOYLTDKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMEFLOXACIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Okacyn"],"synonyms":["Lomefloxacin","Maxaquin","SC-47111A"],"crossReferences":{"PubChem":["174007186","90340951"],"Wikipedia":["Lomefloxacin"],"drugbank":["DB00978"],"chEBI":["116278"]},"childChemblIds":["CHEMBL2106827","CHEMBL3765217","CHEMBL1728"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for eye infection and bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL572284","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO","inchiKey":"IXWNTLSTOZFSCM-YVACAVLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMBRABULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC7700","AVE-8062","AVE8062","Ave8062","Ombrabulin"],"crossReferences":{"drugbank":["DB12882"]},"childChemblIds":["CHEMBL585539"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL576127","canonicalSmiles":"O=C1NCC2(CCN(CCc3ccccc3)CC2)O1","inchiKey":"FVNFBBAOMBJTST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENSPIRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eurespal","Fenspiride"],"crossReferences":{"PubChem":["11111183","11112904","90341038"],"Wikipedia":["Fenspiride"],"drugbank":["DB08979"]},"childChemblIds":["CHEMBL1256849"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL625","canonicalSmiles":"c1ccc2[nH]c(-c3cscn3)nc2c1","inchiKey":"WJCNZQLZVWNLKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIABENDAZOLE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Equizole","Mintezol","Omnizole","Tiabendazole"],"synonyms":["E233","Lombristop","MK-360","Minzolum","NSC-525040","NSC-90507","Nemapan","Omnizole","Pitrizet","Thiabendazole","Thiabenzole","Tiabendazole"],"crossReferences":{"PubChem":["104171300","11112304","124882215","124882217","144203978","144209595","144211287","170464939","17389714","174006224","26746923","26751457","397296","4262837","481912"],"Wikipedia":["Tiabendazole"],"drugbank":["DB00730"],"chEBI":["45979"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967 and is indicated for helminthiasis."}
{"id":"CHEMBL66693","canonicalSmiles":"C[C@@H](N)C(=O)O","inchiKey":"QNAYBMKLOCPYGJ-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-ALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Alanine"],"crossReferences":{"PubChem":["11113403","144204454","170465038","26751643"],"Wikipedia":["Alanine"],"drugbank":["DB01786"],"chEBI":["15570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL70246","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O","inchiKey":"HCYFGRCYSCXKNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEFYLLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acephylline","Caffeine carboxylic acid","Doxophylline metabolite m2","NSC-52996"],"crossReferences":{"PubChem":["170466658"],"Wikipedia":["Acefylline"],"drugbank":["DB13573"]},"childChemblIds":["CHEMBL2106660"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL766","canonicalSmiles":"CC1(C)C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@H](N)C(=O)O)C(=O)O","inchiKey":"DHSUYTOATWAVLW-WFVMDLQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILASTATIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cilastatin","Primaxin"],"crossReferences":{"DailyMed":["cilastatin%20sodium"],"PubChem":["50125939"],"Wikipedia":["Cilastatin"],"drugbank":["DB01597"],"chEBI":["3697"]},"childChemblIds":["CHEMBL1201057"],"linkedTargets":{"rows":["ENSG00000015413"],"count":1},"linkedDiseases":{"rows":["EFO_0003106","HP_0100806","EFO_0003103","EFO_0000771","EFO_1001865","EFO_0000544","EFO_1001141","MONDO_0044881","EFO_0003102","EFO_1001272","EFO_0000465"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 8 investigational indications."}
{"id":"CHEMBL773","canonicalSmiles":"NCC(=O)O","inchiKey":"DHMQDGOQFOQNFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glycolixir"],"synonyms":["Aminoacetic acid","FEMA NO. 3287","Glycine","Glycocoll","NSC-25936"],"crossReferences":{"PubChem":["11113413","144207124","170466831"],"Wikipedia":["Glycine"],"drugbank":["DB00145"],"chEBI":["15428"]},"childChemblIds":["CHEMBL3707233"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL777","canonicalSmiles":"O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21","inchiKey":"HZZVJAQRINQKSD-PBFISZAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAVULANIC ACID","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL 14151","BRL-14151","Clavulanate","Clavulanic Acid","Clavulanic acid","RX-10100","Serdaxin"],"crossReferences":{"DailyMed":["clavulanate%20potassium"],"Wikipedia":["Clavulanic_acid"],"drugbank":["DB00766"],"chEBI":["48947"]},"childChemblIds":["CHEMBL9306","CHEMBL8290","CHEMBL1003"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 6 approved and 32 investigational indications."}
{"id":"CHEMBL83116","canonicalSmiles":"Oc1c(Cl)cc(-c2cc(Cl)c(O)c(Cl)c2)cc1Cl","inchiKey":"YCYDXOVJXVALHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL83116","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03346"],"chEBI":["35434"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL885","canonicalSmiles":"Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F","inchiKey":"XQSPYNMVSIKCOC-NTSWFWBYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EMTRICITABINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emtriva"],"synonyms":["(-)-FTC","(-)-emtricitabine","524-W-91","524W91","BW-524W91","Biktarvy","Coviracil","Emtricitabine","Emtricitabine, (-)-","Emtricitabinum","Emtriva","FTC","FTC-(-)"],"crossReferences":{"DailyMed":["emtricitabine"],"PubChem":["144205746"],"Wikipedia":["Emtricitabine"],"drugbank":["DB00879"],"chEBI":["31536"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL926","canonicalSmiles":"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1","inchiKey":"JRWZLRBJNMZMFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOBUTAMINE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["COMPOUND 81929","COMPOUND-81929","Dl-dobutamine","Dobutamine","Dobutrex","Racemic dobutamine"],"crossReferences":{"PubChem":["104171143","144203677","170465050","26751752","50104446","90341592"],"Wikipedia":["Dobutamine"],"drugbank":["DB00841"],"chEBI":["4670"]},"childChemblIds":["CHEMBL1200418","CHEMBL4297079"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0007372","HP_0100806","EFO_0004610","EFO_0006834","EFO_0003144","EFO_0000373","EFO_0000319","EFO_0009516","MONDO_0043510","HP_0031273","EFO_0005251"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for congestive heart failure and cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL9298","canonicalSmiles":"N#Cc1ccc(C2CCCc3cncn32)cc1","inchiKey":"CLPFFLWZZBQMAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADROZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGS-16949A","Fadrozole"],"crossReferences":{"Wikipedia":["Fadrozole"]},"childChemblIds":["CHEMBL468419"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL997","canonicalSmiles":"CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"MPBVHIBUJCELCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBANDRONIC ACID","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bondronat","Bonviva","Iasibon","Quodixor"],"synonyms":["Bondenza","Boniva","Ibandronate","Ibandronic Acid","Ibandronic acid","Ibandronic acid accord","Ibandronic acid sandoz","Ibandronic acid teva","NSC-722623"],"crossReferences":{"DailyMed":["ibandronate%20sodium"],"PubChem":["90340689"],"Wikipedia":["Ibandronic_acid"],"drugbank":["DB00710"]},"childChemblIds":["CHEMBL1201008","CHEMBL3989569"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0003820","EFO_0001642","MONDO_0007254","EFO_0004260","EFO_0003882","EFO_0003843","EFO_0009708","HP_0002027","HP_0000938","EFO_0001422","EFO_0002690","EFO_0003854","MONDO_0008903","EFO_0000764","EFO_0001378","EFO_0004259","MONDO_0024880"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 11 investigational indications."}
